Generic: 2020 ID HB500 and HB509, Boehringer Ingelheim Pharmaceuticals, Inc.

2020 ID HB500 and HB509 and Boehringer Ingelheim Pharmaceuticals, Inc. have a generic relationship

Opposed by 2020 ID HB500 and HB509
Opponent Boehringer Ingelheim Pharmaceuticals, Inc.
Is Current yes
Updated over 5 years ago

Source Links